FASEX | VMVAX | FASEX / VMVAX | |
Total Expense Ratio | 1.13 | 0.07 | 1,614% |
Annual Report Gross Expense Ratio | 1.22 | 0.07 | 1,743% |
Fund Existence | 38 years | 14 years | - |
Gain YTD | 6.150 | 6.339 | 97% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 360M | 32.5B | 1% |
Annual Yield % from dividends | 0.85 | 2.17 | 39% |
Returns for 1 year | -1.84 | 1.20 | -153% |
Returns for 3 years | 23.52 | 36.10 | 65% |
Returns for 5 years | 57.56 | 63.10 | 91% |
Returns for 10 years | 75.75 | 99.51 | 76% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MDDLX | 8.23 | 0.04 | +0.49% |
MassMutual Diversified Value Adm | |||
TQGIX | 21.14 | 0.07 | +0.33% |
T. Rowe Price Integrated Global Eq I | |||
MPSIX | 22.89 | 0.05 | +0.22% |
Principal MidCap S&P 400 Index Inst | |||
CEUAX | 64.17 | -0.27 | -0.42% |
American Funds EUPAC 529-A | |||
MISAX | 19.71 | -0.09 | -0.45% |
Victory Trivalent International Sm-Cp A |